Observational studyFrontiers in immunology2026
Immune-related adverse events and clinical outcomes in advanced non-small cell lung cancer: does more toxicity predict better outcomes?
Abed Agbarya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.